- Estimated deadline
- Jun 1, 2027
- Expected posting
- Jun 24, 2026
- Award size
- Not listed
- Total program funding
- $27.1M
- Expected awards
- 3
- Cost sharing
- Not required
- Funding type
- Cooperative agreement
- Category
- Health
Check this solicitation free
Grantee reads the full announcement and lists every required section, page limit, deadline, scoring criterion and compliance item. Takes about two minutes, no account needed.
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission through the support of the Clinical Data, Safety and Statistical Centers program. The overall objective of this program is to provide coordination and oversight for multiple activities in service to clinical research and mechanistic studies supported by NIAID, including all Division of Allergy, Immunology, and Transplantation’s Clinical Network activities. This program will provide a broad range of support critical for the design, development, implementation, and analysis of clinical research carried out by multiple division-supported programs in three disease areas: asthma and allergy, autoimmune diseases and transplantation. Support will include statistical design and analysis, protocol development, study initiation and management, data management, safety monitoring, sample tracking, final analysis of study findings, and manuscript development. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Who can apply
- City or township governments
- Federally recognized tribal governments
- County governments
- State governments
- Other (see eligibility)
- Nonprofits with 501(c)(3) status
- For-profit organizations
- Public and state universities
- Independent school districts
- Private universities
- Public and Indian housing authorities
- Small businesses
- Nonprofits without 501(c)(3) status
- Special district governments
- Other Native American tribal organizations
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Agency contact
Division of Allergy, Immunology, and Transplantation
Please contact by email.
- Reads the full solicitation and lays out every required section
- Drafts each section with you, in your words
- Checks the draft against every requirement before you submit
How to write it
All guidesMore from NIH
All NIH funding- Closes in 1 dayRFA-HG-27-011
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
Deadline Oct 30, 2026(1d)Up to $1.3M
- Closes in 1 dayRFA-HG-27-013
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
Deadline Oct 30, 2026(1d)Up to $500K
- Closes in 1 dayRFA-HG-27-012
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
Deadline Oct 30, 2026(1d)Up to $2.3M
- Closes in 1 dayPAR-27-045
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
Deadline Oct 30, 2026(1d)
- Closes in 4 daysPAR-24-280
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Deadline Nov 2, 2026(4d)
- Closes in 4 daysPAR-24-279
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Deadline Nov 2, 2026(4d)
Get new funding every Monday
New federal opportunities and upcoming deadlines for NIH and more, in one short email. Free, unsubscribe anytime.
Details from Grants.gov, last updated Jun 24, 2026. Deadlines and requirements can change: always confirm them in the official notice.